share_log

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Sakiris Spiro Kevin

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities

Intelligent Bio Solutions | 4:持股變動聲明
SEC announcement ·  03/22 07:57
牛牛AI助理已提取核心訊息
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
根據美國證券交易委員會的最新文件,智能生物解決方案(INBS)首席財務官斯皮羅·凱文·薩基里斯於2024年3月20日進行了一次股票交易。薩基里斯通過Anest Holdings Pty Ltd間接收購了Intelligent Bio Solutions的9,394股普通股,該交易編碼爲 “X”。在這次收購之後,Sakiris現在間接持有總計19,180股股票。此外,他直接持有314股普通股。所收購股份的性質是間接的,該交易使他在公司的總實益所有權增加到19,494股。
根據美國證券交易委員會的最新文件,智能生物解決方案(INBS)首席財務官斯皮羅·凱文·薩基里斯於2024年3月20日進行了一次股票交易。薩基里斯通過Anest Holdings Pty Ltd間接收購了Intelligent Bio Solutions的9,394股普通股,該交易編碼爲 “X”。在這次收購之後,Sakiris現在間接持有總計19,180股股票。此外,他直接持有314股普通股。所收購股份的性質是間接的,該交易使他在公司的總實益所有權增加到19,494股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。